(ORIC) |
| 0 (0%) 08-26 15:57 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 17.15 |
| Resistance 1: | 14.68 |
| Pivot price: | 13.76 |
| Support 1: | 12.07 |
| Support 2: | 10.45 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.300 |
| Book Value | 3.680 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -26.0 |
| Return on Equity (ttm) | -39.8 |
Company news
Tue, 25 Aug 2026
Oric Pharmaceuticals (NASDAQ:ORIC) - intelligentinvestor.com.au
Mon, 24 Aug 2026
ORIC Falls After Hours On Safety Concerns Around Prostate Cancer Candidate At Higher Doses - Stocktwits
Sat, 22 Aug 2026
Price to book forward of Oric Pharmaceuticals, Inc. – NASDAQ:ORIC - TradingView
Fri, 07 Aug 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Tue, 04 Aug 2026
Do ORIC Pharmaceuticals’ Widening Losses But Lower Per-Share Losses Reveal a Strategic Trade-Off for ORIC? - simplywall.st
Mon, 03 Aug 2026
ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
